Oman vs Senegal: Death rate from Parkinson's disease
Oman
1.5 deaths per 100,000 people
in 2021
Senegal
1.48 deaths per 100,000 people
in 2021
Oman rank
139th
Senegal rank
140th
Death rate from Parkinson's disease over time
- Oman
- Senegal
How they compare
Oman currently reports 1.5 deaths per 100,000 people against 1.48 deaths per 100,000 people in Senegal, a difference of 0.02 deaths per 100,000 people.
Across all 22 years both countries report, Oman has been ahead every year.
Oman ranks 139th and Senegal ranks 140th of 194 countries.
Oman has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Oman | Senegal | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 1.38 deaths per 100,000 people | 1.27 deaths per 100,000 people | 0.115 deaths per 100,000 people | Oman |
| 2010s | 1.62 deaths per 100,000 people | 1.44 deaths per 100,000 people | 0.188 deaths per 100,000 people | Oman |
| 2020s | 1.73 deaths per 100,000 people | 1.52 deaths per 100,000 people | 0.215 deaths per 100,000 people | Oman |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from parkinson's disease, Oman or Senegal?
- Oman, at 1.5 deaths per 100,000 people against 1.48 deaths per 100,000 people in Senegal as of 2021.
- What is the difference in death rate from parkinson's disease between Oman and Senegal?
- 0.02 deaths per 100,000 people, with Oman ahead.
- How many years of comparable data are there for Oman and Senegal?
- 22 years are reported by both, from 2000 to 2021.
- How do Oman and Senegal rank globally for death rate from parkinson's disease?
- Oman ranks 139th and Senegal ranks 140th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) β with major processing by Our World in Data, published as Death rate from Parkinson's disease. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from parkinson disease in both sexes, per 100,000 people.